Together we will beat cancer

Donate

ScottishPower supports vital research into air pollution and cancer

In November 2021, Cancer Research UK Chief Clinician, Professor Charles Swanton, visited our longstanding corporate partner ScottishPower at their headquarters…

Read More

How targeted screening can help the NHS save lives from lung cancer, the UK’s leading cause of cancer death

Finding lung cancer early makes it much easier to treat. Dr Samantha Quaife, an expert in lung screening, explains how it can save lives and fight inequality.

Read More

Welcome to our new committee chairs

We welcome two outstanding researchers – Kairbaan Hodivala-Dilke and Simon Boulton – as they join our group of funding committee chairs.

Read More

Into the archives: the story of HPV and cervical cancer

From strengthening the understanding of the link between HPV and cervical cancer, to working towards reducing cervical cancer to the point where almost no one develops it, our history with this particular disease goes way back.

Read More

‘Scandinavian quality and Singaporean efficiency’: what the autumn statement means for cancer

With budgets being squeezed by inflation, Jeremy Hunt announced measures to increase tax intakes and put a lid on public spending. But what does it mean for people affected by cancer? 

Read More

‘Being open will help bring awareness’: Meet the fashion vlogger who went public on her diagnosis

This entry is part 5 of 6 in the series Regional Stories

When diagnosed with cancer, deciding how and when to tell people can leave a patient feeling anxious and alone. For…

Read More

Cancer research could revive the UK’s ailing public finances

When the economy faces a slump, investing in research becomes an urgent priority, writes Dr Ian Walker, our executive director of policy, information and communications.

Read More

Research with integrity – the importance of communication

In a new series focussing on research integrity, two of our experts will dig into the issues and challenges of this incredibly important aspect of research.

Read More

NICE recommends pembrolizumab for 1,600 more people with breast cancer

The “potentially life-saving” immunotherapy drug pembrolizumab is now recommended for some people with early triple negative breast cancer in England and Wales.

Read More

Thinking outside the chromosome – how ecDNA is challenging conventional thinking

What is extrachromosomal DNA? How have we come to think of its role in cancer? And what has all this got to do with a flagship lung cancer study?

Read More